Seizure freedom · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints may leads to higher seizure freedom ( compared with valproate (low certainty).
1 finding from 1 review
50% or greater reduction in seizure frequency · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints showed no clear difference in 50% or greater reduction in seizure frequency ( compared with valproate (low certainty).
1 finding from 1 review
Post‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · participants with generalised epilepsy
1 finding from 1 review
Frequency of adverse effects ‐ dizziness ( · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints showed no clear difference in frequency of adverse effects ‐ dizziness ( compared with valproate (low certainty).
1 finding from 1 review
Frequency of adverse effects ‐ malaise ( · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints showed no clear difference in frequency of adverse effects ‐ malaise ( compared with valproate (low certainty).
1 finding from 1 review
Nausea · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints showed no clear difference in frequency of adverse effects ‐ nausea ( compared with valproate (low certainty).
1 finding from 1 review
Frequency of adverse effects ‐ anorexia ( · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints may leads to lower frequency of adverse effects ‐ anorexia ( compared with valproate (low certainty).
1 finding from 1 review